MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Thyroglossal Cyst

(UMLS:C0040124)

Definition:: A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. (Dorland, 27th ed)
UMLS ID:: C0040124
MeSH ID:: D013955

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.182.902

Synonym(s)

Thyroglossal Cyst

Cyst;thyroglossal

THYROGLOSSAL DUCT CYST

Thyroglossal Duct Cyst

Thyroglossal cyst

Thyroglossal duct cyst

Thyroglossal duct/cyst

Thyroglossal duct/cyst/

Thyrolingual Cyst

10.

cyst duct thyroglossal

11.

cyst; thyroglossal

12.

cyst; thyroglossal duct

13.

cysts thyroglossal

14.

thyroglossal cyst

15.

thyroglossal cysts

Associated Drug(s)

	Name	Number of Reports	Data Source
1	NuvaRing	FAERS: 2	US FAERS
2	Thyroxine	FAERS: 2	US FAERS
3	4-hydroxybutyric acid	FAERS: 1	US FAERS
4	Tacrolimus	FAERS: 1	US FAERS
5	Allopurinol		OFFSIDES
6	lamivudine, zidovudine drug combination		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Follicular cyst	42.9%
2	Mucocele	42.9%
3	Pilonidal Cyst	42.9%
4	Synovial Cyst	42.9%
5	Dermoid Cyst	33.3%
6	Lymphocele	28.6%
7	Pancreatic Cyst	28.6%
8	Breast Cyst	27.9%
9	Mediastinal Cyst	27.9%
10	Parovarian Cyst	27.9%
11	Pericardial Cyst	27.9%
12	Thymic Cyst	27.9%
13	Myxoid cyst	27.9%
14	Hamartoma	23.1%
15	Neoplasms, Hormone-Dependent	23.1%
16	Neoplasms, Multiple Primary	23.1%
17	Paraneoplastic Syndromes	23.1%
18	Precancerous Conditions	23.1%
19	Neoplasms, Second Primary	23.1%
20	Pancreatic Pseudocyst	20.5%
21	Corpus Luteum Cyst	20.4%
22	Ovarian Cysts	20.4%
23	Choledochal Cyst	16.7%
24	Neoplastic Processes	15%
25	Neoplastic Syndromes, Hereditary	15%
26	Pregnancy Complications, Neoplastic	15%
27	Carcinoma, Ehrlich Tumor	14.9%
28	Carcinoma, Lewis Lung	14.9%
29	Polycystic Ovary Syndrome	14.9%
30	Carcinoma 256, Walker	14.8%
31	Neoplasms, Experimental	14.6%
32	Abdominal Neoplasms	14.3%
33	Erythroplasia	14.3%
34	Head and Neck Neoplasms	14.3%
35	leukemia	14.3%
36	Neoplasms, Germ Cell and Embryonal	14.3%
37	Neoplasms, Glandular and Epithelial	14.3%
38	Soft Tissue Neoplasms	14.3%
39	Thoracic Neoplasms	14.3%
40	Germ Cell Cancer	14.3%
41	Aberrant Crypt Foci	14.3%
42	Neuroectodermal Tumors	13.6%
43	Neoplasms, Neuroepithelial	13.3%
44	Gliomatosis cerebri	13.3%
45	Multiple Endocrine Neoplasia	12.8%
46	melanoma	12.4%
47	Carcinosarcoma	12.4%
48	Hemangiosarcoma	12.4%
49	Leukemia L1210	12.4%
50	Leukemia P388	12.4%
51	lymphangiosarcoma	12.4%
52	Acanthoma	12.4%
53	Paraneoplastic Encephalomyelitis	12.3%
54	Trophoblastic Neoplasms	12.1%
55	Leukemia, Experimental	12%
56	Mammary Neoplasms, Experimental	12%
57	Medulloblastoma	11.9%
58	Melanoma, Experimental	11.8%
59	Sarcoma 180	11.7%
60	Adenoma, Acidophil	11.5%
61	Ganglioneuroma	11.5%
62	Glioma	11.5%
63	Malignant Glioma	11.5%
64	Basal cell carcinoma	11.1%
65	Carcinoma, Papillary	11.1%
66	Squamous cell carcinoma	11.1%
67	Chondrosarcoma	11.1%
68	Craniopharyngioma	11.1%
69	Cystadenoma	11.1%
70	leiomyosarcoma	11.1%
71	liposarcoma	11.1%
72	Mesothelioma	11.1%
73	synovial sarcoma	11.1%
74	Neuroectodermal Tumor, Melanotic	11.1%
75	Angiomyolipoma	11.1%
76	Clear Cell Sarcoma of Soft Tissue	11.1%
77	Alveolar Soft Part Sarcoma	11.1%
78	Neuroendocrine Tumors	11.1%
79	Sarcoma, Myeloid	11.1%
80	Carcinoma, Basal Cell	11.1%
81	Carcinoid Tumor	11%
82	Neurilemmoma	11%
83	Hutchinson's Melanotic Freckle	11%
84	Melanoma, Amelanotic	11%
85	Sarcoma, Experimental	11%
86	Meningioma	11%
87	Neoplasms, Radiation-Induced	10.8%
88	Astrocytoma	10.6%
89	Ependymoma	10.6%
90	oligodendroglioma	10.6%
91	Ganglioglioma	10.6%
92	gliosarcoma	10.6%
93	Anaplastic astrocytoma	10.6%
94	Anaplastic Oligodendroglioma	10.6%
95	Cystadenocarcinoma	10.5%
96	Fibrosarcoma	10.5%
97	Osteosarcoma	10.5%
98	Mucoepidermoid Carcinoma	10.5%
99	Adenoma	10.3%
100	Ameloblastoma	10.3%
101	Angiokeratoma	10.3%
102	Carcinoma	10.3%
103	Chordoma	10.3%
104	Hemangioma	10.3%
105	hemangiopericytoma	10.3%
106	Lymphangioma	10.3%
107	Malignant Carcinoid Syndrome	10.3%
108	Mesenchymoma	10.3%
109	Nevus	10.3%
110	Retroperitoneal Neoplasms	10.3%
111	Teratoma	10.3%
112	Hepatoblastoma	10.3%
113	Mixed Tumor, Mullerian	10.3%
114	Germinoma	10.3%
115	Teratocarcinoma	10.3%
116	Angiofibroma	10.3%
117	Sarcoma	10.3%
118	Epithelioma	10.3%
119	Choriocarcinoma	10.2%
120	Carcinoma, Lobular	10.2%
121	Adenofibroma	10.2%
122	Fibroadenoma	10.2%
123	Malignant Fibrous Histiocytoma	10.2%
124	Glioblastoma	10.1%
125	Neuroblastoma	10.1%
126	Glioblastoma Multiforme	10.1%
127	Basal Cell Nevus Syndrome	10.1%
128	Digestive System Neoplasms	10%
129	Endocrine Gland Neoplasms	10%
130	Eye Neoplasms	10%
131	Nervous System Neoplasms	10%
132	Ganglioneuroblastoma	9.9%
133	Bowen's Disease	9.9%
134	Paraganglioma	9.9%
135	Rhabdomyosarcoma	9.9%
136	Giant Cell Tumor of Bone	9.9%
137	Leukemia, Radiation-Induced	9.7%
138	Dermatofibrosarcoma	9.6%
139	Dermatofibrosarcoma Protuberans	9.6%
140	Bone neoplasms	9.5%
141	Leukoplakia	9.5%
142	Skin Neoplasms	9.5%
143	Hematologic Neoplasms	9.5%
144	Multiple Endocrine Neoplasia Type 1	9.4%
145	Barrett Esophagus	9.3%
146	Histiocytic Disorders, Malignant	9.3%
147	Actinic keratosis	9.3%
148	Neoplasm Invasiveness	9.3%
149	Neoplasm Metastasis	9.3%
150	Neoplasm Recurrence, Local	9.3%
151	Splenic Neoplasms	9.3%
152	Carcinogenesis	9.3%
153	Metastasis	9.3%
154	Pheochromocytoma	9.3%
155	Alveolar rhabdomyosarcoma	9.3%
156	Thymoma	9.2%
157	Leukemia, Plasma Cell	9.2%
158	Adenocarcinoma	8.5%
159	Carcinoma in Situ	8.5%
160	Carcinoma, Transitional Cell	8.5%
161	Phyllodes Tumor	8.5%
162	Dysgerminoma	8.5%
163	Hemangioendothelioma	8.5%
164	Lipoma	8.5%
165	Myoma	8.5%
166	Myxoma	8.5%
167	Neuroma	8.5%
168	Papilloma	8.5%
169	Pseudomyxoma Peritonei	8.5%
170	Seminoma	8.5%
171	Papillomatosis	8.5%
172	Angiolipoma	8.5%
173	Myelolipoma	8.5%
174	Neoplasms, Bone Tissue	8.5%
175	Neoplasms, Fibrous Tissue	8.5%
176	Smooth Muscle Tumor	8.5%
177	Adenomatosis, Pulmonary	8.5%
178	Adenomatous Polyps	8.5%
179	Carcinoma, Large Cell	8.5%
180	Carcinoma, Small Cell	8.5%
181	Desmoplastic Small Round Cell Tumor	8.5%
182	Chondroma	8.5%
183	Enchondroma	8.5%
184	Parathyroid Neoplasms	8.3%
185	Peritoneal Neoplasms	8.3%
186	Thyroid Neoplasm	8.3%
187	Thyroid carcinoma	8.3%
188	Lymphomatoid Granulomatosis	8.3%
189	Tuberous Sclerosis	8.2%
190	Carcinoid Heart Disease	8.2%
191	Composite Lymphoma	8%
192	Retinoblastoma	7.9%
193	Hydatidiform Mole	7.8%
194	Carcinoma, Pancreatic Ductal	7.7%
195	Tracheal Neoplasms	7.6%
196	Adenoid Cystic Carcinoma	7.6%
197	fibroma	7.6%
198	Fibromatosis	7.6%
199	Osteoblastoma	7.6%
200	Osteoma	7.6%
201	Rhabdomyoma	7.6%
202	Chondromatosis	7.6%
203	Adenocarcinoma, Clear Cell	7.6%
204	Cholangiocarcinoma	7.6%
205	Cervical Intraepithelial Neoplasia	7.6%
206	Hemangioblastoma	7.6%
207	Lymphoma, Extranodal NK-T-Cell	7.6%
208	Leukoplakia, Oral	7.4%
209	Paraneoplastic Cerebellar Degeneration	7.3%
210	Liver Neoplasms, Experimental	7.3%
211	Acoustic Neuroma	7.3%
212	Neurofibrosarcoma	7.1%
213	Fibromatosis, Aggressive	7.1%
214	Fibromatosis, Abdominal	7.1%
215	Klatskin Tumor	7.1%
216	Vipoma	7.1%
217	Mouth Neoplasms	7%
218	Pancreatic Neoplasm	7%
219	Central Nervous System Neoplasms	7%
220	Vascular Neoplasms	7%
221	Thymus Neoplasms	7%
222	Radicular Cyst	6.9%
223	Lymphoma	6.9%
224	Endometrial Stromal Sarcoma	6.9%
225	Genital Neoplasms, Female	6.8%
226	Plasmacytoma	6.8%
227	Nephroblastoma	6.8%
228	Malignant histiocytosis	6.7%
229	Lymphatic Metastasis	6.7%
230	Neoplasms, Unknown Primary	6.7%
231	Leukemic Infiltration	6.7%
232	Breast Neoplasms, Male	6.7%
233	Histiocytic sarcoma	6.7%
234	Neoplasm Micrometastasis	6.7%
235	Triple Negative Breast Neoplasms	6.7%
236	Thyroid Nodule	6.7%
237	Hepatocellular Adenoma	6.7%
238	Lymphangioleiomyomatosis	6.6%
239	Optic Nerve Glioma	6.4%
240	insulinoma	6.3%
241	Esophageal Neoplasms	6.1%
242	Gastrinoma	6.1%
243	Glucagonoma	6.1%
244	Limbic Encephalitis	6.1%
245	Meningeal Neoplasms	5.6%
246	Leukemia, Myelomonocytic, Chronic	5.6%
247	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	5.6%
248	Prolactinoma	5.5%
249	Growth Hormone-Secreting Pituitary Adenoma	5.5%
250	Adenomatous Polyposis Coli	5.5%
251	Peutz-Jeghers Syndrome	5.4%
252	Leydig Cell Tumor	5.3%
253	Lambert-Eaton Myasthenic Syndrome	5.3%
254	Testicular Neoplasms	5.3%
255	Adrenal Gland Neoplasms	5.3%
256	Gastrointestinal Neoplasms	5.3%
257	Genital Neoplasms, Male	5.3%
258	Liver neoplasms	5.3%
259	Uveal Neoplasms	5.3%
260	Urologic Neoplasms	5.2%
261	Sebaceous Gland Neoplasms	5.1%
262	Spinal Neoplasms	5.1%
263	Bone Marrow Neoplasms	5.1%
264	Mastocytoma	5%
265	Hodgkin Disease	5%
266	Lymphoma, Non-Hodgkin	5%
267	Meningeal Carcinomatosis	5%
268	Mastocytosis, Systemic	5%
269	Leukemia, Myeloid, Chronic-Phase	4.9%
270	Mesoblastic Nephroma	4.9%
271	Adrenocortical carcinoma	4.9%
272	granulosa cell tumor	4.7%
273	Carcinoma, Ovarian Epithelial	4.7%
274	Opsoclonus-Myoclonus Syndrome	4.6%
275	Palatal Neoplasms	4.5%
276	Ear Neoplasms	4.3%
277	Eyelid Neoplasms	4.3%
278	Lung Neoplasms	4.3%
279	Pleural Neoplasms	4.3%
280	Nose Neoplasms	4.3%
281	Mastocytosis	4.3%
282	Sturge-Weber Syndrome	4.3%
283	Cell Transformation, Viral	4.2%
284	Brain Neoplasms	4.2%
285	Salivary Gland Neoplasms	4.2%
286	Spinal Cord Neoplasms	4.2%
287	Tongue Neoplasms	4.2%
288	Gastrointestinal Stromal Tumors	4.2%
289	Renal Cell Carcinoma	4.2%
290	Hemangioma, Cavernous	4.2%
291	Papillary Renal Cell Carcinoma	4.2%
292	Leukemia, T-Cell	4.1%
293	Uterine Neoplasms	4.1%
294	Vaginal Neoplasms	4.1%
295	Vulvar Neoplasms	4.1%
296	Uterine Cancer	4.1%
297	Leukemia, B-Cell	4.1%
298	Fallopian Tube Neoplasms	4.1%
299	neurofibroma	4.1%
300	Lymphoma, Follicular	4.1%
301	T-Cell Lymphoma	4.1%
302	Mantle cell lymphoma	4.1%
303	Myelitis, Transverse	4%
304	Carcinoma, Endometrioid	4%
305	Primary amyloidosis	4%
306	Bronchial Neoplasms	3.8%
307	Denys-Drash Syndrome	3.8%
308	Multiple Pulmonary Nodules	3.8%
309	Nasopharyngeal carcinoma	3.8%
310	Pituitary Adenoma	3.7%
311	Pituitary Neoplasms	3.7%
312	Supratentorial Neoplasms	3.7%
313	Endometrial Neoplasms	3.7%
314	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.7%
315	Leukemia, Large Granular Lymphocytic	3.7%
316	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.7%
317	Lymphoma, T-Cell, Cutaneous	3.7%
318	Lymphoma, AIDS-Related	3.7%
319	Enteropathy-Associated T-Cell Lymphoma	3.7%
320	Primary Effusion Lymphoma	3.7%
321	Dupuytren Contracture	3.6%
322	Urticaria Pigmentosa	3.5%
323	Pharyngeal Neoplasms	3.5%
324	Brain Stem Neoplasms	3.5%
325	Mycosis Fungoides	3.4%
326	Lymphomatoid Papulosis	3.4%
327	Plasmablastic lymphoma	3.4%
328	Central Nervous System Cysts	3.4%
329	ovarian neoplasm	3.4%
330	Bile Duct Neoplasms	3.4%
331	gallbladder neoplasm	3.4%
332	Intestinal Neoplasms	3.4%
333	Penile Neoplasms	3.4%
334	Prostatic Neoplasms	3.4%
335	Stomach Neoplasms	3.4%
336	Choroid Plexus Papilloma	3.3%
337	Polycythemia Vera	3.3%
338	Hypopharyngeal Neoplasms	3%
339	Pleural Effusion, Malignant	3%
340	Hypopharyngeal Cancer	3%
341	Xeroderma Pigmentosum	3%
342	Parotid Neoplasms	3%
343	Prostatic Neoplasms, Castration-Resistant	3%
344	Nelson Syndrome	2.9%
345	Laryngeal neoplasm	2.9%
346	Waldenstrom Macroglobulinemia	2.9%
347	Multiple Myeloma	2.9%
348	Tonsillar Neoplasms	2.8%
349	Cerebellar Neoplasms	2.8%
350	Bladder Neoplasm	2.8%
351	Kidney Neoplasm	2.8%
352	Ureteral Neoplasms	2.8%
353	Urethral Neoplasms	2.8%
354	Zollinger-Ellison syndrome	2.5%
355	Cecal Neoplasms	2.5%
356	Duodenal Neoplasms	2.5%
357	Burkitt Lymphoma	2.4%
358	Sezary Syndrome	2.3%
359	Appendiceal Neoplasms	2.3%
360	Colonic Neoplasms	2.3%
361	Rectal Neoplasms	2.3%
362	Nasopharyngeal Neoplasms	2.1%
363	Colorectal Neoplasms	2.1%
364	Anus Neoplasms	1.9%
365	Sigmoid Neoplasms	1.9%
366	Paranasal Sinus Neoplasms	1.9%
367	Maxillary Sinus Neoplasms	1.7%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234